Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous and aggressive hematologic malignancy that is associated with a high relapse rate and poor prognosis. Despite advances in immunotherapies in solid tumors and other hematologic malignancies, AML has been particularly difficult to treat with immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurska, Lindsay, Gritsman, Kira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571054/
https://www.ncbi.nlm.nih.gov/pubmed/37842238
http://dx.doi.org/10.20517/cdr.2023.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571054/
https://www.ncbi.nlm.nih.gov/pubmed/37842238
http://dx.doi.org/10.20517/cdr.2023.39

Ejemplares similares